The top Five Reasons on Why Authors Choose Current Biotechnology

E-ISSN： 2211-551x|6|1|2-4

ISSN： 2211-5501

Source： Current Biotechnology, Vol.6, Iss.1, 2017-01, pp. : 2-4

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The convergence of biotechnology and nanotechnology: Why here, why now?

By Thomas Tom C Acuña-Narvaez Rachelle

Journal of Commercial Biotechnology, Vol. 12, Iss. 2, 2006-01 ,pp. : 105-110

Palgrave Macmillan Ltd

Access to resources Recommend Favorite

Commercial biotechnology in Latin America: Current opportunities and challenges

By Quezada Fernando

Journal of Commercial Biotechnology, Vol. 12, Iss. 3, 2006-04 ,pp. : 192-199

Palgrave Macmillan Ltd

Access to resources Recommend Favorite

Current and future prospects for the global biotechnology industry

By Kermani Faiz

Journal of Commercial Biotechnology, Vol. 10, Iss. 2, 2003-12 ,pp. : 154-161

Palgrave Macmillan Ltd

Access to resources Recommend Favorite

Editorial (Thematic Issue: Current Advances in Algae Biotechnology)

Current Biotechnology, Vol. 4, Iss. 4, 2015-11 ,pp. : 387-388

Bentham Science Publishers

Access to resources Recommend Favorite

Preface: Back to the Future: Current Biotechnology in Perspective

Current Biotechnology, Vol. 6, Iss. 1, 2017-01 ,pp. : 1-1

Bentham Science Publishers

Access to resources Recommend Favorite